Data / Form D filings / Wallkill BioPharma Inc.
Wallkill BioPharma Inc.: Form D filing
Wallkill BioPharma Inc., a biotechnology company in Wilmington, DE, filed a Form D with the SEC in 2018. The latest, on March 28, 2018, reports $207,513 sold of a $207,513 offering to 6 investors.
Find out what Wallkill BioPharma Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1013 CENTRE ROAD, SUITE 403-B, Wilmington, DE, 19805
- Phone
- (858) 900-1521
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1735845
The full lists. Form D filings in Delaware: 1,342 rows, $67.10, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 28, 2018 | New notice | $207,513 | $207,513 | $0 | 6 | Oct 22, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| GERALD SWISS | Executive Officer, Director | |
| MARTIN BELL | Executive Officer, Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Mar 26, 2018 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Wallkill BioPharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.